ArticleCentral European journal of urology2025
Implementation and early outcomes of Da Vinci SP® Robot-Assisted partial nephrectomy via supine anterior retroperitoneal access: Italian single centre experience.
Article in Central European journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Robotic partial nephrectomy is inching toward the gold standard for small renal masses-a narrative review.Translational andrology and urology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The da Vinci SP® Surgical System, approved by the FDA in 2018 for urological procedures and by the European Union in 2024, is now being adopted across Europe. This report presents the first Italian experience with single-port robot-assisted partial nephrectomy (RAPN) using the SP system. Material and methods: From May 8 and May 31, 2024, ten consecutive male patients underwent single-port RAPN via a Lower Anterior retroperitoneal Access (LAA) at a single institution. Perioperative and early postoperative variables were prospectively collected and analyzed. Results: All 10 procedures were completed without conversion to multiport or open surgery. One case was converted to radical nephrectomy for oncologic reasons. Eight procedures were performed on the right kidney and 2 on the left. Median patient age was 72 years (IQR 64-72), median BMI was 28.0 kg/m Conclusions: Single-port RAPN with the da Vinci SP® system is safe and feasible, with promising short-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.